Cardiac and Clinical Phenotype in Barth Syndrome
- 1 August 2006
- journal article
- Published by American Academy of Pediatrics (AAP) in PEDIATRICS
- Vol. 118 (2), e337-e346
- https://doi.org/10.1542/peds.2005-2667
Abstract
OBJECTIVE. Barth syndrome, an X-linked disorder that is characterized by cardiomyopathy, neutropenia, skeletal myopathy, and growth delay, is caused by mutations in the taffazin gene at Xq28 that result in cardiolipin deficiency and abnormal mitochondria. The clinical phenotype in Barth syndrome has not been characterized systematically, and the condition may be underrecognized. We sought to evaluate extent of cardioskeletal myopathy, potential for arrhythmia, delays in growth, and biochemical correlates of disease severity in patients with this disorder. METHODS. We conducted an observational, cross-sectional study of the largest cohort of patients with Barth syndrome to date (n = 34; age range: 1.2–22.6 years). Evaluation included echocardiography, electrocardiography (standard and signal-averaged), microvolt T wave alternans analysis, biochemical and hematologic laboratory analyses, and physical therapy evaluation of skeletal myopathy. RESULTS. Family history was positive for confirmed or suspected Barth syndrome in 63%. Ninety percent of patients had a clinical history of cardiomyopathy (mean age at diagnosis of cardiomyopathy: 5.5 months; at genetic confirmation of Barth syndrome: 4.6 years). Echocardiography revealed a mean ejection fraction of 50% ± 10%, mean fractional shortening of 28% ± 5%, and mean left ventricular end-diastolic volume z score of 1.9 ± 1.8. Left ventricular morphology demonstrated increased trabeculations or true noncompaction in 53%. Of 16 patients who were evaluated at ≥11 years of age, 7 (43%) had documented ventricular arrhythmia. Growth deficiency was present (mean weight percentile: 15%; mean height percentile: 8%). Laboratory analysis revealed low total white blood cell count (absolute count: <4000 cells per μL) in 25% of those who were not on granulocyte colony-stimulating factor. Hypocholesterolemia was present in 24%, decreased low-density lipoprotein cholesterol in 56%, low prealbumin in 79%, and mildly elevated creatine kinase in 15%. CONCLUSIONS. Our cohort demonstrated clinical variability, but most had cardiomyopathy and diminished growth velocity, with a propensity toward neutropenia and low cholesterol. There was increased incidence of ventricular arrhythmia, predominantly in adolescents and young adults. Barth syndrome should be considered when boys present with cardiomyopathy, especially when associated with increased left ventricular trabeculations, neutropenia, skeletal muscle weakness, or family history indicating an X-linked pattern of inheritance.This publication has 36 references indexed in Scilit:
- Acquired noncompaction in Duchenne muscular dystrophyInternational Journal of Cardiology, 2006
- Barth syndrome: TAZ gene mutations, mRNAs, and evolutionAmerican Journal of Medical Genetics Part A, 2005
- Clinical Characterization of Left Ventricular Noncompaction in ChildrenCirculation, 2003
- Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathyHeart, 2001
- Preliminary evidence for a cognitive phenotype in Barth syndromeAmerican Journal of Medical Genetics, 2001
- X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)—MIM 302060The Journal of Pediatrics, 1999
- Normal values and methodologic recommendations for signal-averaged electrocardiography in children and adolescentsThe American Journal of Cardiology, 1996
- X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduriaThe Journal of Pediatrics, 1991
- Clinical course of idiopathic dilated cardiomyopathy in childrenJournal of the American College of Cardiology, 1991
- Grip and Pinch Strength: Norms for 6- to 19-Year-OldsAmerican Journal of Occupational Therapy, 1986